EuroPCR 2019: TAVI embolic protection device scoops DeHaan Award for Innovation

Giora Weisz (New York, USA) talks to BLearning after receiving the DeHaan Award for Innovation at EuroPCR 2019 (21–24 May, Paris, France) for his presentation and development of a full-body embolic protection device for use in TAVI procedures.

Weisz notes that despite TAVI becoming a widely used procedure, “some of the patients have cerebrovascular events, mainly strokes”. As such, he believes that there is room for the procedure to be “even safer than it is right now”. The way to prevent strokes, he says, is to avoid procedural debris from reaching the cerebral circulation.

Weisz believes the judges chose his innovation as there is a “an increased interest in protecting patients during TAVI” and that the decision recognised the need for embolic protection devices that are “very simple to deploy and extract, do not interfere with the valve and protect the full-body”.

Weisz also looks at which patients undergoing TAVI procedures need cerebral protection, which he notes is a “struggle” because at the moment “we cannot predict which patients will suffer from strokes”. He also compares his own novel device with Sentinel (Boston Scientific).

Giora Weisz is a Medical Advisory Board Member of Filterlex, which is the company behind the device being discussed.

Disclaimer: The views and opinions expressed in this video are those of the interviewee/s and do not necessarily reflect the opinion of BLearning. BLearning did not receive any industry or financial support in the making of this video.

Weisz, Giora

Giora Weisz is Director of Interventional Cardiology at Montefiore Medical Center in New York. He is also Faculty Member at the Cardiovascular Research Foundation. Weisz was previously Chairman of Cardiology at Shaare Zedek Medical Center in Jerusalem and an Associate Professor at Columbia University.

Add comment

Editor’s Cardiovascular Pick

    Subscribeto receive the very best in medical videos